Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

How Big Is Celgene's Latest Good News?

TheMotleyFool

0 0

How Big Is Celgene's Latest Good News?Photo, wide shot, wide-angle lens, Medical device manufacturer, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/3a7f6312-1eee-4702-9005-93cc1e62f970.png

After a couple of years of mainly bad news, Celgene (NASDAQ: CELG) is enjoying a streak of good news so far in 2019.

The biotech won U.S. Food and Drug Administration (FDA) approval for a combination of Revlimid and Rituxan in May as a second-line treatment for follicular lymphoma or marginal zone lymphoma. It received FDA approval in June for Otezla in treating Behcet's disease. And on Friday, Celgene announced that the FDA approved Inrebic (fedratinib) in treating myelofibrosis.

Just how big is Celgene's latest good news? Maybe a $1 billion-per-year kind of big.

Source Fool.com

Like: 0

CELG

Share